Literature DB >> 20619369

Expanding the clinical spectrum of SLC29A3 gene defects.

Ronen Spiegel1, Simon T Cliffe, Michael F Buckley, Yanick J Crow, Jill Urquhart, Yoseph Horovitz, Yardena Tenenbaum-Rakover, William G Newman, Dian Donnai, Stavit A Shalev.   

Abstract

H syndrome and pigmented hypertrichosis with insulin dependent diabetes (PHID) are allelic autosomal recessive syndromes reported in the last year to be caused by mutations in the SLC29A3 gene, which encodes the equilibrative nucleoside transporter hENT3. Herein, we report three new patients from a single family who present with phenotypes that associate features of both PHID and H syndrome. Genetic analysis of the SLC29A3 gene revealed that two affected sisters are compound heterozygotes for the previously reported mutations p.G427S and p.G437R, while their nephew was homozygous for the p.G437R mutation. In addition to this intra-familial genetic heterogeneity, these patients demonstrate considerable phenotypic variability. One sister had clinical features consistent with classical PHID phenotype, while her nephew's features were in keeping with the diagnosis of H syndrome. The second sister displayed the most severe phenotype which combined diagnostic features from both syndromes. This patient also had features not described previously, including severe seronegative polyarthritis involving large and small joints, and hypogonadotropic hypogonadism. These manifestations may be additional characteristics of the growing clinical spectrum of SLC29A3 defects. This report emphasizes the complex genotype phenotype correlation in SLC29A3 disorders and suggests that other factors are relevant to disease manifestations and severity.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619369     DOI: 10.1016/j.ejmg.2010.06.012

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

1.  Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.

Authors:  Philippe M Campeau; James T Lu; Gautam Sule; Ming-Ming Jiang; Yangjin Bae; Simran Madan; Wolfgang Högler; Nicholas J Shaw; Steven Mumm; Richard A Gibbs; Michael P Whyte; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-08-08       Impact factor: 6.150

2.  Dysosteosclerosis is also caused by TNFRSF11A mutation.

Authors:  Long Guo; Nursel H Elcioglu; Ozge K Karalar; Mert O Topkar; Zheng Wang; Yuma Sakamoto; Naomichi Matsumoto; Noriko Miyake; Gen Nishimura; Shiro Ikegawa
Journal:  J Hum Genet       Date:  2018-03-22       Impact factor: 3.172

3.  Accelerated coronary atherosclerosis and H syndrome.

Authors:  Ravindranath K Shankarappa; Rajiv Ananthakrishna; Ravi S Math; Sachin Dhareppa Yalagudri; Satish Karur; Ramesh Dwarakaprasad; Manjunath C Nanjappa; Vered Molho-Pessach
Journal:  BMJ Case Rep       Date:  2011-10-04

4.  A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.

Authors:  Alexandre Bolze; Avinash Abhyankar; Audrey V Grant; Bhavi Patel; Ruchi Yadav; Minji Byun; Daniel Caillez; Jean-Francois Emile; Marçal Pastor-Anglada; Laurent Abel; Anne Puel; Rajgopal Govindarajan; Loic de Pontual; Jean-Laurent Casanova
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

Review 5.  Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.

Authors:  Marçal Pastor-Anglada; Sandra Pérez-Torras
Journal:  Front Pharmacol       Date:  2015-02-10       Impact factor: 5.810

6.  H syndrome: 5 new cases from the United States with novel features and responses to therapy.

Authors:  Jessica L Bloom; Clara Lin; Lisa Imundo; Stephen Guthery; Shelly Stepenaskie; Csaba Galambos; Amy Lowichik; John F Bohnsack
Journal:  Pediatr Rheumatol Online J       Date:  2017-10-17       Impact factor: 3.054

7.  The histopathology and phenotypic variability in H syndrome.

Authors:  David Dias-Polak; Margarita Indelman; Reuven Bergman; Emily Avitan-Hersh
Journal:  Clin Case Rep       Date:  2018-01-25

Review 8.  A novel homozygous frame-shift mutation in the SLC29A3 gene: a new case report and review of literature.

Authors:  Sadaf Noavar; Samira Behroozi; Taraneh Tatarcheh; Farshid Parvini; Majid Foroutan; Hossein Fahimi
Journal:  BMC Med Genet       Date:  2019-08-29       Impact factor: 2.103

Review 9.  Atypical comorbidities in a child considered to have type 1 diabetes led to the diagnosis of SLC29A3 spectrum disorder.

Authors:  Özge Besci; Kashyap Amratlal Patel; Gizem Yıldız; Özlem Tüfekçi; Kübra Yüksek Acinikli; İbrahim Mert Erbaş; Ayhan Abacı; Ece Böber; Meral Torun Bayram; Şebnem Yılmaz; Korcan Demir
Journal:  Hormones (Athens)       Date:  2022-03-14       Impact factor: 3.419

10.  Pseudo-Meigs' Syndrome in Tunisian H Syndrome Female Patient: First Case Reported.

Authors:  Yosra Zaimi; Myriam Ayari; Asma Mensi; Linda Bel Hadj Kacem; Leila Achouri; Meriem Bouzrara; Yosra Said; Leila Mouelhi; Radhouane Debbeche
Journal:  Appl Clin Genet       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.